FDA Indications: An alternative drug for treatment-resistant depression (not considered a first-line drug of choice) FDA approved for treating major depression mixed anxiety and depression and phobic or hypochondriacal features FDA approved for treating atypical depression (e.g
More serious but rare effects include acute pancreatitis or thyroid dysfunction
Allergic reactions (rash, itching, swelling)
And this then helps more serotonin be released because you're not having so much inflammation getting into the brain and affecting serotonin release
Muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage ( cholinergic crisis ) An important complication that can arise is obstruction of the airway by bronchial secretions Pharmacokinetics: IV and IM administration Rapid renal excretion, resulting in a short duration of action of 5-10 mins Major drug Interactions: Care should be given when administering this drug to patients with symptoms of myasthenic weakness who are also on anticholinesterase drugs Since symptoms of anticholinesterase overdose (cholinergic crisis) may mimic underdosage (myasthenic weakness), their condition may be worsened by the use of this drug Figure 2
Dispose of used syringes in a sharps container